Amphetamine effects on dopamine release and synthesis rate studied in the Rhesus monkey brain by positron emission tomography
The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Abstract
Positron emission tomography (PET) was used in a multitracer protocol to evaluate D-amphetamine induced effects on dopamine biosynthesis rate and release in propofol anesthetized Rhesus monkeys. L-[beta-11C]DOPA was used as biochemical probe to study the brain dopamine biosynthesis rate whilst dopamine release was followed by the binding displacement of the [11C]-radiolabelled dopamine receptor antagonists, raclopride and N-methylspiperone. Studies were performed with either a constant rate intravenous infusion of D-amphetamine aiming at plasma concentrations of 0.2 to 25 ng/ml or with intravenous bolus doses of 0.1 and 0.4 mg/kg. Decreased binding of the dopamine receptor antagonists was measured in both modes of D-amphetamine administration but notably [11C]N-methylspiperone was less able to sense D-amphetamine induced release of dopamine. At plasma concentrations aimed above 1 ng/ml a levelling off of the binding of [11C]raclopride at 68 +/- 8.1% of the baseline value indicated that displacement was only possible from a fraction of the binding sites. Amphetamine was observed to increase the rate constant for L-[beta-11C]DOPA utilization in the brain. This was most likely due to an acutely induced subsensitivity of presynaptic dopamine receptors. L-[beta-11C]DOPA and [11C]raclopride were found suitable to indicate changes in dopamine synthesis rate and release respectively using PET and can be used to mirror drug-induced changes of brain dopaminergic function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476 · cited 1×
“It has been shown in knock-out mice that a lack of functional dopamine transporters resulted in no biochemical or behavioral response to D-amphetamine (Giros et al., 1996).”
BackgroundBrain blood flow measured with intravenous H2(15)O. II. Implementation and validation.
Raichle, M. E., Martin, W. R. W., Herscovitch, P., Mintun, M. A., & Markham, J. (1983) · PubMed · Cited by 1,015
Brain blood flow measured with intravenous H2(15)O. I. Theory and error analysis.
Herscovitch, P., Markham, J., & Raichle, M. E. (1983) · PubMed · Cited by 835
Zetterström, T., Sharp, T., Marsden, C. A., & Ungerstedt, U. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb00893.x · Cited by 616
BURT, D. R., CREESE, I., & SNYDER, S. H. (1976) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10800-6 · Cited by 475 · cited 1×
“The binding affinity of D-amphetamine to D2dopamine receptors is low (Burt et al., 1976) so competition for binding with the two radiotracers is therefore not likely.”
BackgroundKuczenski, R., & Segal, D. (1989) · The Journal of Neuroscience · doi:10.1523/jneurosci.09-06-02051.1989 · Cited by 398
Brooks, D. J., Ibanez, V., Sawle, G. V., Playford, E. D., Quinn, N., Mathias, C. J., Lees, A. J., Marsden, C. D., Bannister, R., & Frackowiak, R. S. J. (1992) · Annals of Neurology · doi:10.1002/ana.410310209 · Cited by 396 · cited 1×
“cerebellum are insignificant ( Brooks et al., 1992 ).”
Seeman, P., Guan, H. ‐., & Niznik, H. B. (1989) · Synapse · doi:10.1002/syn.890030113 · Cited by 293 · cited 1×
“D-amphetamine is a potent releaser of monoamines (McMillen, 1983) and has been utilized to sense dopamine release to the synaptic cleft as a decreased binding of dopaminergic antagonists in the brain of rats and monkeys ( Seeman et al., 1989; Young et al., 1991; Dewey et al., 1991, 1993; Innis et al., 1992).”
BackgroundAmphetamine‐Induced Dopamine Release in the Rat Striatum: An In Vivo Microdialysis Study
Butcher, S. P., Fairbrother, I. S., Kelly, J. S., & Arbuthnott, G. W. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb02919.x · Cited by 288 · cited 1×
“Taking into account previous reports of D-amphetamine dramatically increased striatal dopamine concentrations (Zetterstr6m et al., 1983; Kuczenski and Segal, 1989) using the microdialysis technique in freely moving rats, the present results might be explained by a release of a newly synthetized pool of dopamine ( Butc…”
ResultDewey, S. L., Smith, G. S., Logan, J., Brodie, J. D., Fowler, J. S., & Wolf, A. P. (1993) · Synapse · doi:10.1002/syn.890130407 · Cited by 283
Research works printed but not linked: 5
- Dexamphetamine (1991) In: Dollery C et al. (eds) Therapeutic drugs, vol 1. Churchill Livingstone, Edinburgh, pp D50-D55
- Edling C, Hellman B, Arvidsson B, Lilja A, Andersson J, Hartvig P, Valind S, L�ngstr�m B (1997) Positron emission tomography studies of subjects occupationally exposed organic solvents. Evidence of increased dopamine synthesis rate. Int Arch Occup Environ Health (in press)
- Laruelle M, Iyer RN, Al-Tikritit MS, Zea-Ponce Y, Malison R, Zoghbi SS, Baldwin RM, Kung HF, Charney DS, Hoffer PB, Innis RB, Bradberry CW (1997) Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates. Synapse 25: 1?14 · DOI · Paper page
- L�ngstr�m B, Antoni G, Halldin C, Gullberg P, Malmborg P, N�gren K, Rimland A, Sv�rd H (1987) Synthesis of L- and D-(methyl11C)methionine. J Nucl Med 28: 1037?1040
- Tedroff J, Torstenson R, Hartvig P, Lindner KJ, Watanabe Y, Bjurling P, Westerberg G, L�ngstr�m B (1997) L-DOPA modulates striatal dopaminergic function in vivo: evidence from PET investigations in nonhuman primates. Synapse 25: 56?61 · doi:10.1002/(sici)1098-2396(199701)25:1<56::aid-syn7>3.0.co;2-e
Cited by
Howes, O. D., Kambeitz, J., Kim, E., Stahl, D., Slifstein, M., Abi-Dargham, A., & Kapur, S. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2012.169 · Cited by 967
Imaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review
Laruelle, M. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200003000-00001 · Cited by 944
Increased dopamine transmission in schizophrenia: relationship to illness phases
Laruelle, M., Abi-Dargham, A., Gil, R., Kegeles, L., & Innis, R. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00067-0 · Cited by 715
Pruessner, J. C., Champagne, F., Meaney, M. J., & Dagher, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3422-03.2004 · Cited by 709
“There is considerable evidence that manipulations that lead to an increase in synaptic dopamine in the striatum are associated with proportional reductions in binding of this tracer (Breier et al., 1997; Endres et al., 1997; Hartvig et al., 1997; Laruelle et al., 1997; Laruelle, 2000).”
BackgroundAmphetamine-induced dopamine release in human ventral striatum correlates with euphoria
Drevets, W. C., Gautier, C., Price, J. C., Kupfer, D. J., Kinahan, P. E., Grace, A. A., Price, J. L., & Mathis, C. A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01038-6 · Cited by 706
Small, D. M., Jones-Gotman, M., & Dagher, A. (2003) · NeuroImage · doi:10.1016/s1053-8119(03)00253-2 · Cited by 632
“It is assumed that a reduction in [ 11 C]raclopride BP is indicative of an increase in extracellular dopamine concentration (Endres et al., 1997; Hartvig et al., 1997; Fig.”
BackgroundFaraone, S. V. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.02.001 · Cited by 631
“…increased [11C]raclopride (a D2 receptor antagonist) binding affinity after 1 day of drug withdrawal and with binding after 7 and 14 days of withdrawal in cynomolgus monkeys, as measured by PET Hartvig et al. (1997) • AMP increased DA biosynthesis in the brain in nonhuman primates, as measured by…”
Alcohol promotes dopamine release in the human nucleus accumbens
Boileau, I., Assaad, J., Pihl, R. O., Benkelfat, C., Leyton, M., Diksic, M., Tremblay, R. E., & Dagher, A. (2003) · Synapse · doi:10.1002/syn.10226 · Cited by 591
“…including combined PET microdialysis studies, that the binding of benzamides such as [11C]raclopride is sensitive and proportional to extracellular dopamine concentration in the striatum (Endres et al., 1997; Ginovart et al., 1997; Hartvig et al., 1997; Laruelle et al., 1997; Laruelle, 2000).”
BackgroundMethodStrafella, A. P. (2003) · Brain · doi:10.1093/brain/awg268 · Cited by 559
“There is considerable evidence that in vivo binding of benzamide tracers such as [11C]raclopride is inversely proportional to levels of synaptic dopamine at the time of the scan (Dewey et al., 1993; Breier et al., 1997; Endres et al., 1997; Hartvig et al., 1997; Laruelle et al., 1997; Laruelle, 2000).”
BackgroundSmoking-Induced Ventral Striatum Dopamine Release
Brody, A. L., Olmstead, R. E., London, E. D., Farahi, J., Meyer, J. H., Grossman, P., Lee, G. S., Huang, J., Hahn, E. L., & Mandelkern, M. A. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.7.1211 · Cited by 347
“(9, 19), cocaine (20, 21), and amphetamine (22, 23) admin-”
Lindström, L. H., Gefvert, O., Hagberg, G., Lundberg, T., Bergström, M., Hartvig, P., & Långström, B. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00109-2 · Cited by 284
Self-citationDopamine Transmission in the Human Striatum during Monetary Reward Tasks
Zald, D. H., Boileau, I., El-Dearedy, W., Gunn, R., McGlone, F., Dichter, G. S., & Dagher, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4643-03.2004 · Cited by 238
“Increases in DA transmission lead to reductions in [ (11)C]raclopride BP in the striatum (Dewey et al., 1993; Breier et al., 1997; Endres et al., 1997; Hartvig et al., 1997; Laruelle, 2000), whereas decreases in DA transmission produce increases in [ (11)C]raclopride BP (Dewey et al.”
BackgroundDopaminergic Function in Cannabis Users and Its Relationship to Cannabis-Induced Psychotic Symptoms
Bloomfield, M. A. P., Morgan, C. J. A., Egerton, A., Kapur, S., Curran, H. V., & Howes, O. D. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.05.027 · Cited by 215
Ventral Striatal Dopamine Release in Response to Smoking a Regular vs a Denicotinized Cigarette
Brody, A. L., Mandelkern, M. A., Olmstead, R. E., Allen-Martinez, Z., Scheibal, D., Abrams, A. L., Costello, M. R., Farahi, J., Saxena, S., Monterosso, J., et al. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.87 · Cited by 183
“…here with smoking a regular cigarette was less than the 20–29% increase found with cocaine (Volkow et al, 1999; Park and Park, 2000) or the 19–31% increase found with amphetamine (Carson et al, 1997; Hartvig et al, 1997; Drevets et al, 1999) administration in studies using similar methodology.”
MethodResultInfluentialShotbolt, P., Tziortzi, A. C., Searle, G. E., Colasanti, A., van der Aart, J., Abanades, S., Plisson, C., Miller, S. R., Huiban, M., Beaver, J. D., et al. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.115 · Cited by 155
“A dosedependent relationship between amphetamine dose and changes in ligand binding (Breier et al, 1997; Hartvig et al, 1997; Laruelle et al, 1997), as well as a consistent relationship between the concentration of extracellular dopamine change and the change in radioligand binding (Breier et al,…”
BackgroundStress-Induced Dopamine Release in Humans at Risk of Psychosis: a [11C]Raclopride PET Study
Soliman, A., O’Driscoll, G. A., Pruessner, J. C., Holahan, A.-L. V., Boileau, I., Gagnon, D., & Dagher, A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301597 · Cited by 171
PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum
Drevets, W. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00079-2 · Cited by 122
PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756
Abi-Dargham, A., Simpson, N., Kegeles, L., Parsey, R., Hwang, D.-R., Anjilvel, S., Zea-Ponce, Y., Lombardo, I., Van Heertum, R., Mann, J. J., et al. (1999) · Synapse · doi:10.1002/(sici)1098-2396(199905)32:2<93::aid-syn3>3.0.co;2-c · Cited by 115
The link between dopamine function and apathy in cannabis users: an [18F]-DOPA PET imaging study
Bloomfield, M., Morgan, C. J. A., Kapur, S., Curran, H. V., & Howes, O. D. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3523-4 · Cited by 110
“We calculated the influx rate constant of [ 18 F ]-DOPA uptake in each ROI relative to the cerebellum [K i cer (min −1 )] using the Patlak graphical analysis adapted for a reference tissue input function (Hartvig et al. 1991, 1997; Hoshi et al. 1993; Patlak and Blasberg 1985 ).”
MethodSun, W., Ginovart, N., Ko, F., Seeman, P., & Kapur, S. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.456 · Cited by 99
Impact of D2 Receptor Internalization on Binding Affinity of Neuroimaging Radiotracers
Guo, N., Guo, W., Kralikova, M., Jiang, M., Schieren, I., Narendran, R., Slifstein, M., Abi-Dargham, A., Laruelle, M., Javitch, J. A., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.189 · Cited by 80
“Time course studies revealed maximal D 2 receptor internalization of about 58% following quinpirole treatment with a t 1/2 of 5.3 ± 0.7 min (Figure 2B2).”
InfluentialRadiotracer imaging of dopaminergic transmission in neuropsychiatric disorders
Verhoeff, N. P. L. G. (1999) · Psychopharmacology · doi:10.1007/s002130051163 · Cited by 88
Ginovart, N. (2004) · Molecular Imaging and Biology · doi:10.1007/s11307-005-0932-0 · Cited by 85
Saba, W., Cavorsin, M. L., Ginovart, N., Zimmer, L., Gualda, V., Bonnefoi, F., & Leviel, V. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-0904-4 · Cited by 77
Harvey, D. C., Laćan, G., & Melega, W. P. (2000) · Experimental Brain Research · doi:10.1007/s002210000386 · Cited by 60
Ruskin, D. N., Bergstrom, D. A., Shenker, A., Freeman, L. E., Baek, D., & Walters, J. R. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00987-2 · Cited by 61
Imaging methods for evaluating brain function in man
KESSLER, R. M. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00047-2 · Cited by 67
“Conversely, release of dopamine by d-amphetamine or blockade of re-uptake into the neuron by methylphenidate can produce a 10–20% decrease in [11C]-raclopride or [123I]-IBZM binding [34,61,74,92,119,148,173,174].”
BackgroundNarendran, R., Jedema, H. P., Lopresti, B. J., Mason, N. S., Gurnsey, K., Ruszkiewicz, J., Chen, C.-M., Deuitch, L., Frankle, W. G., & Bradberry, C. W. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.9 · Cited by 54
Morris, E. D., & Yoder, K. K. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600359 · Cited by 54
“Endogenous DA appears to alter the measured specific binding of some ligands (Hume et al, 1992; Dewey et al, 1993; Hartvig et al, 1997; Mukherjee et al, 1997; Okauchi et al, 2001; Narendran et al, 2004; Slifstein et al, 2004; Mukherjee et al, 2005) but not of others (al-Tikriti et al, 1994; Hartvig…”
BackgroundFunctional dynamics of dopamine synthesis during monetary reward and punishment processing
Hahn, A., Reed, M. B., Pichler, V., Michenthaler, P., Rischka, L., Godbersen, G. M., Wadsak, W., Hacker, M., & Lanzenberger, R. R. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x211019827 · Cited by 55
Laruelle, M. A. (2012) · Neuromethods · doi:10.1007/7657_2012_45 · Cited by 47
Boecker, H., Henriksen, G., Sprenger, T., Miederer, I., Willoch, F., Valet, M., Berthele, A., & Tölle, T. R. (2008) · Methods · doi:10.1016/j.ymeth.2008.07.003 · Cited by 44
Tsukada, H., Harada, N., Nishiyama, S., Ohba, H., & Kakiuchi, T. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02057-6 · Cited by 39
Klimas, M. T. (2002) · Molecular Imaging and Biology · doi:10.1016/s1536-1632(02)00017-3 · Cited by 42
Ishiwata, K., Koyanagi, Y., Abe, K., Kawamura, K., Taguchi, K., Saitoh, T., Toda, J., Senda, M., & Sano, T. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00619.x · Cited by 33
Torstenson, R., Tedroff, J., Hartvig, P., Fasth, K., & Lågström, B. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199910000-00011 · Cited by 30
Self-citationShegani, A., Kealey, S., Luzi, F., Basagni, F., Machado, J. D. M., Ekici, S. D., Ferocino, A., Gee, A. D., & Bongarzone, S. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00398 · Cited by 29
Recycling Systems Based on Screen-Printed Electrodes
Lisdat, F., Ho, W. O., Wollenberger, U., Scheller, F. W., Richter, T., & Bilitewski, U. (1998) · Electroanalysis · doi:10.1002/(sici)1521-4109(199809)10:12<808::aid-elan808>3.0.co;2-k · Cited by 29
Mapping the amphetamine-evoked dopamine release in the brain of the Gottingen minipig
Lind, N. M., Olsen, A. K., Moustgaard, A., Jensen, S. B., Jakobsen, S., Hansen, A. K., Arnfred, S. M., Hemmingsen, R. P., Gjedde, A., & Cumming, P. (2005) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2004.08.007 · Cited by 28
Thomsen, G. K., Knudsen, G. M., Jensen, P. S., Ziebell, M., Holst, K. K., Asenbaum, S., Booij, J., Darcourt, J., Dickson, J. C., Ozlem Kapucu, L., et al. (2013) · EJNMMI Research · doi:10.1186/2191-219x-3-39 · Cited by 28
“However, the reduction in D2/3 binding upon smoking compared to the baseline condition is modest (5% to 10%) in these studies compared to that following cocaine (20% to 30%) [16] and amphetamine [17-19].”
ResultZimmer, L., Hassoun, W., Pain, F., Bonnefoi, F., Lanièce, P., Mastrippolito, R., Pinot, L., Pujol, J. F., & Leviel, V. (2002) · PubMed · Cited by 29
Effects of Amphetamine and Evoked Dopamine Release on [11C]raclopride Binding in Anesthetized Cats
Ginovart, N., Hassoun, W., Cavorsin, M. L., Veyre, L., Bars, D. L., & Leviel, V. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00285-3 · Cited by 29
Sequential H(2)(15)O PET studies in baboons: before and after amphetamine.
Price, J. C., Drevets, W. C., Ruszkiewicz, J., Greer, P. J., Villemagne, V. L., Xu, L., Mazumdar, S., Cantwell, M. N., & Mathis, C. A. (2002) · PubMed · Cited by 26
Salience attribution and its relationship to cannabis-induced psychotic symptoms
Bloomfield, M., Mouchlianitis, E. D., Morgan, C. J. A., Freeman, T. P., Curran, H. V., Roiser, J. P., & Howes, O. D. (2016) · Psychological Medicine · doi:10.1017/s0033291716002051 · Cited by 24
Positron‐labeled DOPA analogs to image dopamine terminals
DeJesus, O. T. (2003) · Drug Development Research · doi:10.1002/ddr.10223 · Cited by 23
“…which is a cofactor of AAAD, were found to increase dopamine synthesis [Tsukada et al., 1996; Tedroff et al., 1997], while amphetamine challenge and apomorphine infusion were found to decrease dopamine synthesis via negative feedback [Hartvig et al., 1997; Torstenson et al., 1998].”
BackgroundBellés, L., Dimiziani, A., Tsartsalis, S., Millet, P., Herrmann, F. R., & Ginovart, N. (2020) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa084 · Cited by 20
Logan, J., Fowler, J. S., Dewey, S. L., Volkow, N. D., & Gatley, S. J. (2001) · Journal of Neural Transmission · doi:10.1007/s007020170073 · Cited by 18
Ishiwata, K., Mizuno, M., Kimura, Y., Kawamura, K., Oda, K., Sasaki, T., Nakamura, Y., Muraoka, I., & Ishii, K. (2004) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2004.06.003 · Cited by 17
Radiopharmaceuticals: Molecular Imaging using Positron Emission Tomography
Antoni, G., & Långström, B. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-72718-7_9 · Cited by 15
Self-citationLettfuss, N. Y., Fischer, K., Sossi, V., Pichler, B. J., & von Ameln-Mayerhofer, A. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.06.051 · Cited by 15
Yamamoto, Y., Takahata, K., Kubota, M., Takano, H., Takeuchi, H., Kimura, Y., Sano, Y., Kurose, S., Ito, H., Mimura, M., et al. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117543 · Cited by 15
Quelch, D. R., Withey, S. L., Nutt, D. J., Tyacke, R. J., & Parker, C. A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.05.040 · Cited by 14
Beyond monoamines: II. Novel applications for PET imaging in psychiatric disorders
Royse, S. K., Lopresti, B. J., Mathis, C. A., Tollefson, S., & Narendran, R. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15657 · Cited by 26
“…of clinically effective doses of neuroleptic drugs that bind to D2 receptors (Farde et al., 1986; Hagberg et al., 1998) in a dose- dependent manner; this effect was significantly attenuated using [11C]NMSP (Goyer et al., 1996; Hartvig et al., 1997), if not absent altogether (Hagberg et al., 1998).”
Kim, S. E., & Han, S. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009826 · Cited by 11
Use of positron emission tomography in analysing receptor function in vivo
Hartvig, P., Bergström, M., & Långström, B. (2001) · Toxicology Letters · doi:10.1016/s0378-4274(01)00300-9 · Cited by 14
Self-citationWilcox, K. M., Zhou, Y., Wong, D. F., Alexander, M., Rahmim, A., Hilton, J., & Weed, M. R. (2008) · Synapse · doi:10.1002/syn.20565 · Cited by 10
“However, in the middle of the study, saffan became unavailable and some scans for one monkey (04-185) were performed using propofol [adapted from (Hartvig et al., 1997)].”
Ishiwata, K., Koyanagi, Y., Saitoh, T., Taguchi, K., Toda, J., SANO, T., & Senda, M. (2001) · Journal of Neural Transmission · doi:10.1007/s007020170001 · Cited by 10
Ishiwata, K., Kobayashi, T., Kawamura, K., Matsuno, K., & Senda, M. (2001) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(01)00238-4 · Cited by 10
Abe, K., Hosoi, R., Momosaki, S., Kobayashi, K., Ibii, N., & Inoue, O. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03194-3 · Cited by 5
Hartvig, P., Nordberg, A. K., Torstenson, R., Sjöberg, P., Fasth, K. J., & Långström, B. (2002) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000057697 · Cited by 3
Self-citationTiger, M., & Lundberg, J. (2022) · Neuromethods · doi:10.1007/978-1-0716-2083-0_11 · Cited by 1
Amphetamine-Induced Dopamine Release Greater in Ventral Than in Dorsal Striatum
Price, J. C., Drevets, W. C., Kinahan, P. E., Lopresti, B. J., & Mathis, C. A. (2001) · Elsevier eBooks · doi:10.1016/b978-012285751-5/50035-1 · Cited by 1
Assessment of Dopamine and Serotonin Release in the Non-Human Primate Brain using PET
Finnema, S. J. (2011) · Figshare
Molecular imaging of dopamine synthesis and release
Shotbolt, J. (2013) · Spiral (Imperial College London) · doi:10.25560/11152
“A dose-dependent relationship between amphetamine dose and changes in ligand binding (Breier et al. 1997; Hartvig et al. 1997; Laruelle et al. 1997), as well as a consistent relationship between the concentration of extracellular DA change and the change in radioligand binding (Breier et al. 1997;…”
Reply to “The Value of Functional PET in Quantifying Neurotransmitter Dynamics”
Morris, E. D., Emvalomenos, G. M., Hoye, J., & Meikle, S. R. (2025) · Journal of Nuclear Medicine · doi:10.2967/jnumed.125.269473
“The observations, originally published as early as 1997 ( 11,12 ), report that the change in binding potential ( D BP) of raclopride in response to large doses of amphetamine tops out at 40%.”
Développement préclinique et clinique du [18F]F13640 pour l'imagerie des récepteurs 5-HT1A cérébraux
Colom, M. (2020) · theses.fr (ABES) · doi:10.70675/434f5a8bz8c8ez4bf4z979czc7fa7eb94950
Mapping dynamics in neuronal activation and molecular connectivity with functional PET
Hahn, A., Reed, M. B., Falb, P., Murgaš, M., Milz, C., Tüchler, S. M., Klug, S., Godbersen, G. M., & Lanzenberger, R. R. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1920555
“Furthermore, dopamine synthesis is increased by amphetamine-induced dopamine release (Kehr et al., 1977; Hartvig et al., 1997), which also applies to serotonin synthesis and fenfluramine (Yamane et al., 1999).”
Metadata
- Authors
- Hartvig, P., Torstenson, R., Tedroff, J., Watanabe, Y., Fasth, K. J., Bjurling, P., & L�ngstr�m, B.
- Affiliations
- Uppsala University (SE)
- Venue
- Journal of Neural Transmission
- Published
- 1997-04
- Volume
- 104
- Issue
- 4-5
- Pages
- 329-339
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2087276569
- Cited by
- 70
- References
- 35
- Citations by year
- 2026: 1 · 2025: 1 · 2022: 3 · 2021: 1 · 2020: 3 · 2018: 1 · 2016: 1 · 2014: 2 · 2013: 5 · 2012: 3
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neural Transmission (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- amphetamine, dopamine release, [11C]raclopride, dopamine antagonists, rhesus monkey brain, dopaminergic activity
- MeSH terms
- Amphetamine, Animals, Brain, Cerebrovascular Circulation, Decarboxylation, Dopamine, Female, Levodopa, Macaca mulatta, Salicylamides, Spiperone, Tomography, Emission-Computed, Dopamine Agents, Dopamine Agonists, Dopamine Antagonists, Raclopride
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.